No abstract

No abstract

No abstract

The obesity pandemic has led to metabolic-associated fatty liver disease as being a major cause of chronic liver disease and liver transplantation worldwide. Metabolic and bariatric surgery (MBS), through a significant and sustained weight loss, has been shown to have a positive impact on both liver steatohepatitis and fibrosis. This review article aims to present and critically appraise the current literature on the impact of MBS on liver disease and highlight its increasing acceptance within the liver transplant community.